European Archives - Page 757 of 1117 - European Medical Journal

Editor's Pick: Novel Targets and Therapies in T Cell Lymphoma

This review presents the recent advances in our understanding of the cellular pathogenesis of T cell non-Hodgkin lymphoma (NHL) and the potential of…

Major Determinants of Delayed Access to Innovative Medicines for Metastatic Melanoma: The Results of the Melanoma World Society (MWS) and European Association of Dermato-Oncology (EADO) Survey

At the 2018 European Society for Medical Oncology (ESMO) Congress in Munich, Germany, the Melanoma World Society (MWS) and European Association of…

Recent Advances in the Treatment of Metastatic Soft Tissue Sarcoma

Soft tissue sarcomas (STS) are a rare group of heterogeneous malignancies with >50 histologic subtypes that have varying biological behaviour and…

Clinical Issues for Prostate-Specific Antigen Screening: A Narrative Review

Prostate cancer, with its remarkably high prevalence, frequently creates clinical problems in terms of screening and diagnosis, as well as identifying…

Mantle Cell Lymphoma: Are New Therapies Changing the Standard of Care?

The prognosis of mantle cell lymphoma (MCL) has improved rapidly over recent years with the evolution of new management strategies. The disease, once…

EMJ

Dr Jyoti Dabholkar

Professor Emeritus, Department of ENT and HN Surgery, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical…

EMJ

Dr Jad Degheili

Division of Urology, Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon…

EMJ

Prof Paul Dent

Professor and Universal Chair in Signal Transduction, Department of Biochemistry & Molecular Biology, Virginia Commonwealth…

EMJ

Dr Divyanshu Dua

Medical Oncologist, Canberra Hospital, New South Wales, Australia…

EMJ

Dr Abdulmajeed Hammadi

Iraqi Stem Cell Center, Alyermook Teaching Hospital, Baghdad, Iraq…